The expression rates of LAT1 vary across different types of cancers, as follows: 53 % in pancreatic cancer, 43 % in breast cancer, 60 % in non-small cell lung cancer, and 80 % in colorectal cancer [16]. Here, SLC7A5 is linked to pancreatic neoplasm.